Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
2.980
-0.060 (-1.97%)
Aug 24, 2026, 4:00 PM EDT - Market closed
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $78.32 million as of August 25, 2026. Its market cap has decreased by -59.34% in one year.
Market Cap
78.32M
Enterprise Value
68.99M
1-Year Change
-59.34%
Ranking
Category
Stock Price
$2.98
ChartMarket Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $78.32M, a decrease of -74.91%. That is a compound annual growth rate of -34.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 78.32M | -43.70% |
| Dec 31, 2025 | 139.10M | 153.09% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
| Jun 2, 2023 | 312.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Verrica Pharmaceuticals | 83.66M |
| Cingulate | 82.60M |
| MAIA Biotechnology | 82.11M |
| Eloxx Pharmaceuticals | 80.69M |
| Telomir Pharmaceuticals | 80.47M |
| OKYO Pharma | 78.72M |
| Alterity Therapeutics | 78.58M |
| Cardiff Oncology | 77.64M |